HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giampiero Girolomoni Selected Research
Giampiero Girolomoni Research Topics
Disease
99
Psoriasis (Pustulosis Palmaris et Plantaris)
05/2024 - 07/2002
35
Atopic Dermatitis (Atopic Eczema)
05/2024 - 03/2002
19
Inflammation (Inflammations)
03/2023 - 03/2002
17
Psoriatic Arthritis
03/2024 - 06/2004
14
Skin Diseases (Skin Disease)
08/2022 - 01/2002
12
Allergic Contact Dermatitis
03/2010 - 01/2002
11
Pruritus (Itching)
09/2022 - 03/2009
9
Infections
03/2023 - 10/2005
6
Eczema
09/2022 - 10/2008
6
Neoplasms (Cancer)
03/2022 - 03/2010
6
Dermatitis
01/2022 - 12/2003
6
Virus Diseases (Viral Diseases)
12/2020 - 04/2002
6
Necrosis
01/2019 - 12/2003
5
Prurigo
03/2024 - 12/2013
5
Pain (Aches)
03/2023 - 06/2014
4
Arthritis (Polyarthritis)
03/2024 - 11/2012
4
COVID-19
12/2022 - 01/2021
4
Hypersensitivity (Allergy)
09/2022 - 11/2008
4
Rheumatoid Arthritis
12/2020 - 01/2007
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 10/2009
4
Lichen Planus (Lichen Ruber Planus)
11/2020 - 08/2005
4
Autoimmune Diseases (Autoimmune Disease)
09/2020 - 12/2014
3
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2024 - 07/2014
3
Obesity
06/2022 - 12/2016
3
Melanoma (Melanoma, Malignant)
03/2022 - 12/2006
3
Bullous Pemphigoid (Pemphigoid)
03/2022 - 01/2021
3
Colorectal Neoplasms (Colorectal Cancer)
01/2011 - 01/2007
3
Contact Dermatitis (Eczema, Contact)
10/2008 - 07/2003
2
Basal Cell Carcinoma (Rodent Ulcer)
03/2024 - 07/2015
2
Uveitis
03/2024 - 01/2018
2
Hidradenitis Suppurativa
03/2024 - 01/2020
2
Acne Vulgaris
01/2024 - 08/2021
2
Alopecia Areata
12/2023 - 08/2021
2
Pyoderma Gangrenosum
12/2022 - 11/2002
2
Injection Site Reaction
12/2022 - 12/2018
2
Opportunistic Infections (Opportunistic Infection)
12/2022 - 06/2004
2
Blister (Bulla)
03/2022 - 12/2013
2
Urticaria (Hives)
11/2021 - 03/2021
2
Hypertension (High Blood Pressure)
10/2021 - 01/2019
2
Dyslipidemias (Dyslipidemia)
10/2021 - 01/2019
Drug/Important Bio-Agent (IBA)
15
Etanercept (Enbrel)
FDA Link
12/2020 - 06/2004
13
Adalimumab (Humira)
FDA Link
03/2024 - 09/2007
12
Biosimilar Pharmaceuticals
IBA
04/2024 - 07/2014
11
dupilumab
IBA
03/2024 - 07/2020
11
Cytokines
IBA
12/2022 - 03/2002
10
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2020 - 11/2002
9
Methotrexate (Mexate)
FDA Link
Generic
12/2023 - 01/2006
9
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2023 - 11/2008
9
secukinumab
IBA
01/2023 - 06/2014
9
Infliximab (Remicade)
FDA Link
12/2020 - 06/2004
8
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 06/2014
8
Chemokines
IBA
07/2019 - 01/2002
7
Monoclonal Antibodies
IBA
01/2024 - 08/2012
7
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2023 - 08/2005
6
Interleukins
IBA
08/2022 - 10/2005
6
Antibodies
IBA
03/2022 - 06/2004
5
ixekizumab
IBA
05/2024 - 06/2014
5
Vaccines
IBA
12/2022 - 04/2002
5
Haptens
IBA
11/2008 - 01/2002
4
Ustekinumab (CNTO 1275)
FDA Link
04/2024 - 08/2012
4
Janus Kinase Inhibitors
IBA
01/2024 - 01/2018
4
Interleukin-12 (IL 12)
IBA
01/2023 - 08/2012
4
brodalumab
IBA
01/2023 - 06/2014
4
Allergens
IBA
09/2022 - 03/2002
4
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 07/2003
4
Proteins (Proteins, Gene)
FDA Link
01/2021 - 07/2002
4
apremilast
IBA
06/2020 - 01/2016
3
upadacitinib
IBA
01/2024 - 11/2023
3
Interleukin-4 (Interleukin 4)
IBA
12/2023 - 08/2005
3
Janus Kinases
IBA
11/2023 - 01/2018
3
Advanced Glycation End Products
IBA
03/2023 - 07/2017
3
Interleukin-23 (Interleukin 23)
IBA
01/2023 - 08/2012
3
Interleukin-13
IBA
12/2022 - 10/2005
3
Immunoglobulin A (IgA)
IBA
09/2022 - 12/2011
3
Immunoglobulin G (IgG)
IBA
03/2022 - 06/2014
3
Imiquimod (Aldara)
FDA Link
Generic
01/2022 - 01/2017
3
Antimicrobial Peptides
IBA
09/2020 - 12/2006
3
Enzymes
IBA
01/2019 - 04/2010
3
Immunomodulating Agents
IBA
01/2018 - 07/2010
3
Cetuximab (Erbitux)
FDA Link
01/2016 - 01/2007
3
efalizumab (Raptiva)
FDA Link
01/2009 - 01/2006
3
Nickel
IBA
11/2008 - 06/2002
2
ABP 501
IBA
12/2023 - 12/2022
2
abrocitinib
IBA
08/2023 - 09/2022
2
tralokinumab
IBA
07/2023 - 12/2022
2
Biomarkers (Surrogate Marker)
IBA
03/2023 - 01/2022
2
Methylprednisolone
FDA Link
Generic
12/2022 - 03/2022
2
HLA-C Antigens (HLA-C)
IBA
11/2022 - 01/2021
2
Nivolumab
IBA
03/2022 - 10/2020
2
Steroids
IBA
01/2022 - 01/2015
2
Antirheumatic Agents (DMARD)
IBA
01/2022 - 11/2012
2
Omalizumab (Xolair)
FDA Link
11/2021 - 12/2017
Therapy/Procedure
45
Therapeutics
05/2024 - 11/2002
14
Biological Therapy
05/2024 - 09/2007
5
Transplantation
12/2020 - 05/2010
4
Phototherapy (Light Therapy)
01/2022 - 12/2010
3
Aftercare (After-Treatment)
09/2022 - 07/2013
3
Balneology
04/2021 - 07/2008
3
Drug Therapy (Chemotherapy)
01/2016 - 01/2007
3
Radiotherapy
10/2015 - 12/2009